Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have published a landmark review on BH3 mimetics—a new class of drugs that are reshaping the ...
Despite the promise of new medications that promote cancer cell death in people with acute myeloid leukemia, leukemic cells often adopt features that let them evade the drugs' effects within a year.
Researchers have developed a novel chronic lymphocytic leukemia (CLL) murine model that expresses human BCL2 in B cells under the TCL1 promoter control, named TBC. These animals showed strong ...
Acute myeloid leukemia (AML) is a type of cancer in which the bone marrow makes a large number of abnormal blood cells. It is the most common type of acute leukemia in adults. For decades, the ...
A cancer-fighting compound being tested in clinical trials for some types of leukemia could also have potential for treating the most common form of breast cancer, a team of Australian researchers ...
Despite the promise of new medications that promote cancer cell death in people with acute myeloid leukemia, leukemic cells often adopt features that let them evade the drugs' effects within a year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results